|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Dizziness | 24.06.02.007; 17.02.05.003; 02.01.02.004 | - | - | |
| Drug abuse | 19.07.02.010 | - | - | Not Available |
| Drug dependence | 19.07.02.009 | 0.000139% | | Not Available |
| Drug hypersensitivity | 10.01.01.001 | - | - | Not Available |
| Dry skin | 23.03.03.001 | - | - | |
| Dysarthria | 19.19.03.001; 17.02.08.001 | 0.000533% | | |
| Dyspepsia | 07.01.02.001 | 0.000799% | | |
| Dysphagia | 07.01.06.003 | 0.001459% | | |
| Dysphonia | 22.02.05.005; 19.19.03.002; 17.02.08.004 | 0.000533% | | |
| Dyspnoea | 22.02.01.004; 02.01.03.002 | 0.005595% | | |
| Dyspnoea exertional | 22.02.01.005; 02.01.03.003 | 0.000533% | | Not Available |
| Dysuria | 20.02.02.002 | - | - | |
| Electrocardiogram QT prolonged | 13.14.05.004 | - | - | |
| Epistaxis | 24.07.01.005; 22.04.03.001 | 0.001598% | | |
| Epstein-Barr virus infection | 11.05.10.004 | 0.000799% | | |
| Erythema | 23.03.06.001 | 0.001598% | | Not Available |
| Erythema infectiosum | 23.03.08.007; 11.05.15.002 | - | - | Not Available |
| Erythroleukaemia | 16.01.05.002; 01.10.05.002 | 0.000139% | | Not Available |
| Essential thrombocythaemia | 16.21.03.004; 01.13.03.003 | 0.000278% | | Not Available |
| Face oedema | 10.01.05.002; 08.01.07.003; 23.04.01.004 | - | - | |
| Facial paralysis | 17.04.03.008 | 0.000533% | | Not Available |
| Fatigue | 08.01.01.002 | - | - | |
| Febrile neutropenia | 08.05.02.004; 01.02.03.002 | 0.001865% | | |
| Feeling abnormal | 08.01.09.014 | - | - | Not Available |
| Femur fracture | 15.08.03.003; 12.04.01.003 | - | - | Not Available |
| Fibrosis | 08.03.01.001 | 0.000533% | | Not Available |
| Folate deficiency | 14.12.02.006 | - | - | Not Available |
| Fracture | 12.04.02.001; 15.08.02.001 | 0.003463% | | |
| Gamma-glutamyltransferase increased | 13.03.01.011 | 0.000799% | | |
| Gangrene | 11.02.01.003; 24.04.05.003; 23.06.06.001 | - | - | Not Available |
